The percentage of CD8+ T cells is significantly lower in severe and critical COVID-19 patients, but unlike NEUT and LYMPH counts, lymphocyte subpopulation analysis is not currently routine clinical practice [16]. The gene discussed is CD8A; the disease is COVID-19.